SEARCH

SEARCH BY CITATION

References

  • Addy, C., Assaid, C., Hreniuk, D., Stroh, M., Xu, Y., Herring, W.J., Ellenbogen, A., Jinnah, H.A., Kirby, L., Leibowitz, M.T., Stewart, R.M., Tarsy, D., Tetrud, J., Stoch, S.A., Gottesdiener, K. & Wagner, J. (2009) Single-dose administration of MK-0657, an NR2B-selective NMDA antagonist, does not result in clinically meaningful improvement in motor function in patients with moderate Parkinson's disease. J Clin Pharmacol 49, 856864.
  • Bäckman, C., You, Z.B., Perlmann, T. & Hoffer, B.J. (2003) Elevated locomotor activity without altered striatal dopamine contents in Nurr1 heterozygous mice after acute exposure to methamphetamine. Behav Brain Res 143, 95100.
  • Braff, D.L., Grillon, C. & Geyer, M.A. (1992) Gating and habituation of the startle reflex in schizophrenic patients. Arch Gen Psychiatry 49, 206215.
  • Braff, D.L., Geyer, M.A. & Swerdlow, N.R. (2001) Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies. Psychopharmacology 156, 234258.
  • Brébion, G., David, A.S., Pilowsky, L.S. & Jones, H. (2004) Recognition of visual stimuli and memory for spatial context in schizophrenic patients and healthy volunteers. J Clin Exp Neuropsychol 26, 10931102.
  • Brown, V.J. & Bowman, E.M. (2002) Rodent models of prefrontal cortical function. Trends Neurosci 25, 340343.
  • Buervenich, S., Carmine, A., Arvidsson, M., Xiang, F., Zhang, Z., Sydow, O., Jönsson, E.G., Sedvall, G.C., Leonard, S., Ross, R.G., Freedman, R., Chowdari, K.V., Nimgaonkar, V.L., Perlmann, T., Anvret, M. & Olson, L. (2000) Nurr1 mutations in cases of schizophrenia and manic-depressive disorder. Am J Med Genet 96, 808813.
  • van den Buuse, M., Garner, B., Gogos, A. & Kusljic, S. (2005) Importance of animal models in schizophrenia research. Aust N Z J Psychiatry 39, 550557.
  • Carmine, A., Buervenich, S., Galter, D., Jönsson, E.G., Sedvall, G.C., Farde, L., Gustavsson, J.P., Bergman, H., Chowdari, K.V., Nimgaonkar, V.L., Anvret, M., Sydow, O. & Olson, L. (2003) NURR1 promoter polymorphisms: Parkinson's disease, schizophrenia, and personality traits. Am J Med Genet B Neuropsychiatr Genet 120, 5157.
  • Chu, Y., Le, W., Kompoliti, K., Jankovic, J., Mufson, E.J. & Kordower, J.H. (2006) Nurr1 in Parkinson's disease and related disorders. J Comp Neurol 494, 495514.
  • Crawley, J.N. (2007) Mouse behavioral assays relevant to the symptoms of autism. Brain Pathol 17, 448459.
  • Crider, A. (1997) Perseveration in schizophrenia. Schizophr Bull 23, 6374.
  • Csomor, P.A., Yee, B.K., Feldon, J., Theodoridou, A., Studerus, E. & Vollenweider, F.X. (2009) Impaired prepulse inhibition and prepulse-elicited reactivity but intact reflex circuit excitability in unmedicated schizophrenia patients: a comparison with healthy subjects and medicated schizophrenia patients. Schizophr Bull 35, 244255.
  • Cui, X., Pelekanos, M., Burne, T.H., McGrath, J.J. & Eyles, D.W. (2010) Maternal vitamin D deficiency alters the expression of genes involved in dopamine specification in the developing rat mesencephalon. Neurosci Lett 486, 220223.
  • Dalley, J.W., Cardinal, R.N. & Robbins, T.W. (2004) Prefrontal executive and cognitive functions in rodents: neural and neurochemical substrates. Neurosci Biobehav Rev 28, 771784.
  • Dellu, F., Mayo, W., Cherkaoui, J., Le Moal, M. & Simon, H. (1992) A two-trial memory task with automated recording: study in young and aged rats. Brain Res 588, 132139.
  • Eells, J.B., Lipska, B.K., Yeung, S.K., Misler, J.A. & Nikodem, V.M. (2002) Nurr1-null heterozygous mice have reduced mesolimbic and mesocortical dopamine levels and increased stress-induced locomotor activity. Behav Brain Res 17, 267275.
  • Eells, J.B., Misler, J.A. & Nikodem, V.M. (2006) Early postnatal isolation reduces dopamine levels, elevates dopamine turnover and specifically disrupts prepulse inhibition in Nurr1-null heterozygous mice. Neuroscience 140, 11171126.
  • Eyles, D.W., Feron, F., Cui, X., Kesby, J.P., Harms, L.H., Ko, P., McGrath, J.J. & Burne, T.H. (2009) Developmental vitamin D deficiency causes abnormal brain development. Psychoneuroendocrinology 34, 247257.
  • Feldon, J. & Weiner, I. (1992) From an animal model of an attentional deficit towards new insights into the pathophysiology of schizophrenia. J Psychiatr Res 26, 345366.
  • Foussias, G. & Remington, G. (2010) Negative symptoms in schizophrenia: avolition and Occam's razor. Schizophr Bull 36, 356359.
  • Geyer, M.A. & Swerdlow, N.R. (1998) Measurement of startle response, prepulse inhibition and habituation. Curr Protoc Neurosci 8, 115.
  • Grimes, D.A., Han, F., Panisset, M., Racacho, L., Xiao, F., Zou, R., Westaff, K. & Bulman, D.E. (2006) Translated mutation in the Nurr1 gene as a cause for Parkinson's disease. Mov Disord 21, 906909.
  • Guillin, O., Abi-Dargham, A. & Laruelle, M. (2007) Neurobiology of dopamine in schizophrenia. Int Rev Neurobiol 78, 139.
  • Hoffman, H.S. & Searle, J.L. (1965) Acoustic variables in the modification of the startle reaction in the rat. J Comp Physiol Psychol 60, 5358.
  • Howes, O.D. & Kapur, S. (2009) The dopamine hypothesis of schizophrenia: version III – the final common pathway. Schizophr Bull 35, 549562.
  • Huang, Y., Cheung, L., Rowe, D. & Halliday, G. (2004) Genetic contributions to Parkinson's disease. Brain Res Brain Res Rev 46, 4470.
  • Jankovic, J., Chen, S. & Le, W.D. (2005) The role of Nurr1 in the development of dopaminergic neurons and Parkinson's disease. Prog Neurobiol 77, 128138.
  • Jiang, C., Wan, X., He, Y., Pan, T., Jankovic, J. & Le, W. (2005) Age-dependent dopaminergic dysfunction in Nurr1 knockout mice. Exp Neurol 191, 154162.
  • Kadkhodaei, B., Ito, T., Joodmardi, E., Mattsson, B., Rouillard, C., Carta, M., Muramatsu, S., Sumi-Ichinose, C., Nomura, T., Metzger, D., Chambon, P., Lindqvist, E., Larsson, N.G., Olson, L., Björklund, A., Ichinose, H. & Perlmann, T. (2009) Nurr1 is required for maintenance of maturing and adult midbrain dopamine neurons. J Neurosci 29, 1592315932.
  • Krystal, J.H., Karper, L.P., Seibyl, J.P., Freeman, G.K., Delaney, R., Bremner, J.D., Heninger, G.R., Bowers, M.B. Jr. & Charney, D.S. (1994) Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Arch Gen Psychiatry 51, 199214.
  • Lahti, A.C., Koffel, B.L., LaPorte, D. & Tamminga, D.A. (1995) Subanesthetic doses of ketamine stimulate psychosis in schizophrenia. Neuropsychopharmacology 13, 919.
  • Lahti, A.C., Weiler, M.A., Tamara Michaelidis, B.A., Parwani, A. & Tamminga, C.A. (2001) Effects of ketamine in normal and schizophrenia volunteers. Neuropsychopharmacology 23, 223239.
  • Le, W., Conneely, O.M., Zou, L., He, Y., Saucedo-Cardenas, O., Jankovic, J., Mosier, D.R. & Appel, S.H. (1999a) Selective agenesis of mesencephalic DA neurons in Nurr1-deficient mice. Exp Neurol 159, 451458.
  • Leng, A., Yee, B.K., Feldon, J. & Ferger, B. (2004) Acoustic startle response, prepulse inhibition, and spontaneous locomotor activity in MPTP-treated mice. Behav Brain Res 154, 449456.
  • Meyer, U. & Feldon, J. (2009) Neural basis of psychosis-related behaviour in the infection model of schizophrenia. Behav Brain Res 204, 322334.
  • Meyer, U. & Feldon, J. (2010) Epidemiology-driven neurodevelopmental animal models of schizophrenia. Prog Neurobiol 90, 285326.
  • Meyer, U., Chang, D.L., Feldon, J. & Yee, B.K. (2004) Expression of the CS- and US-pre-exposure effects in the conditioned taste aversion paradigm and their abolition following systemic amphetamine treatment in C57BL6/J mice. Neuropsychopharmacology 29, 21402148.
  • Meyer, U., Feldon, J., Schedlowski, M. & Yee, B.K. (2005) Towards an immuno-precipitated neurodevelopmental animal model of schizophrenia. Neurosci Biobehav Rev 29, 913947.
  • Meyer, U., Engler, A., Weber, L., Schedlowski, M. & Feldon, J. (2008a) Preliminary evidence for a modulation of fetal dopaminergic development by maternal immune activation during pregnancy. Neuroscience 154, 701709.
  • Meyer, U., Murray, P.J., Urwyler, A., Yee, B.K., Schedlowski, M. & Feldon, J. (2008b) Adult behavioral and pharmacological dysfunctions following disruption of the fetal brain balance between pro-inflammatory and IL-10-mediated anti-inflammatory signaling. Mol Psychiatry 13, 208221.
  • Meyer, U., Nyffeler, M., Yee, B.K., Knuesel, I. & Feldon, J. (2008c) Adult brain and behavioral pathological markers of prenatal immune challenge during early/middle and late fetal development in mice. Brain Behav Immun 22, 469486.
  • Mohn, A.R., Gainetdinov, R.R., Caron, M.G. & Koller, B.H. (1999) Mice with reduced NMDA receptor expression display behaviors related to schizophrenia. Cell 98, 427436.
  • Perriol, M.P., Dujardin, K., Derambure, P., Marcq, A., Bourriez, J.L., Laureau, E., Pasquier, F., Defebvre, L. & Destée, A. (2005) Disturbance of sensory filtering in dementia with Lewy bodies: comparison with Parkinson's disease dementia and Alzheimer's disease. J Neurol Neurosurg Psychiatry 76, 106108.
  • Perry, W., Minassian, A., Paulus, M.P., Young, J.W., Kincaid, M.J., Ferguson, E.J., Henry, B.L., Zhuang, X., Masten, V.L., Sharp, R.F. & Geyer, M.A. (2009) A reverse-translational study of dysfunctional exploration in psychiatric disorders: from mice to men. Arch Gen Psychiatry 66, 10721080.
  • Powell, C.M. & Miyakawa, T. (2006) Schizophrenia-relevant behavioral testing in rodent models: a uniquely human disorder? Biol Psychiatry 59, 11981207.
  • Rojas, P., Joodmardi, E., Hong, Y., Perlmann, T. & Ogren, S.O. (2007) Adult mice with reduced Nurr1 expression: an animal model for schizophrenia. Mol Psychiatry 12, 756766.
  • Rojas, P., Joodmardi, E., Perlmann, T. & Ogren, S.O. (2010) Rapid increase of Nurr1 mRNA expression in limbic and cortical brain structures related to coping with depression-like behavior in mice. J Neurosci Res 88, 22842293.
  • Ruano, D., Macedo, A., Dourado, A., Soares, M.J., Valente, J., Coelho, I., Santos, V., Azevedo, M.H., Goodman, A., Hutz, M.H., Gama, C., Lobato, M.I., Belmonte-de-Abreu, P. & Palha, J.A. (2004) NR4A2 and schizophrenia: lack of association in a Portuguese/Brazilian study. Am J Med Genet B Neuropsychiatr Genet 128, 4145.
  • Saucedo-Cardenas, O., Quintana-Hau, J.D., Le, W.D., Smidt, M.P., Cox, J.J., De Mayo, F., Burbach, J.P. & Conneely, O.M. (1998) Nurr1 is essential for the induction of the dopaminergic phenotype and the survival of ventral mesencephalic late dopaminergic precursor neurons. Proc Natl Acad Sci U S A 95, 40134018.
  • Smidt, M.P. & Burbach, J.P. (2007) How to make a mesodiencephalic dopaminergic neuron. Nat Rev Neurosci 8, 2132.
  • Swerdlow, N.R. & Geyer, M.A. (1998) Using an animal model of deficient sensorimotor gating to study the pathophysiology and new treatments of schizophrenia. Schizophr Bull 24, 285301.
  • Swerdlow, N.R., Geyer, M.A. & Braff, D.L. (2001) Neural circuit regulation of prepulse inhibition of startle in the rat: current knowledge and future challenges. Psychopharmacology 156, 194215.
  • Tamminga, C.A. & Holcomb, H.H. (2005) Phenotype of schizophrenia: a review and formulation. Mol Psychiatry 10, 2739.
  • Tandon, R., Nasrallah, H.A. & Keshavan, M.S. (2009) Schizophrenia, “just the facts” 4. Clinical features and conceptualization. Schizophr Research 110, 123.
  • Valls-Solé, J. (2004) Function and dysfunction of the startle reaction in humans. Rev Neurol 39, 946955.
  • Vuillermot, S., Weber, L., Feldon, J. & Meyer, U. (2010) A longitudinal examination of the neurodevelopmental impact of prenatal immune activation in mice reveals primary defects in dopaminergic development relevant to schizophrenia. J Neurosci 30, 12701287.
  • Weiner, I. (2003) The two-headed latent inhibition model of schizophrenia: modeling positive and negative symptoms and their treatment. Psychopharmacology 169, 257297.
  • Wallén, A., Zetterström, R.H., Solomin, L., Arvidsson, M., Olson, L. & Perlmann, T. (1999) Fate of mesencephalic AHD2-expressing dopamine progenitor cells in Nurr1 mutant mice. Exp Cell Res 253, 737746.
  • Xing, G., Zhang, L., Russell, S. & Post, R. (2006) Reduction of dopamine-related transcription factors Nurr1 and NGFI-B in the prefrontal cortex in schizophrenia and bipolar disorders. Schizophr Res 84, 3656.
  • Yee, B.K. & Feldon, J. (2009) Distinct forms of prepulse inhibition disruption distinguishable by the associated changes in prepulse-elicited reaction. Behav Brain Res 204, 387395.
  • Yee, B.K., Chang, D.L. & Feldon, J. (2004) The effects of dizocilpine and phencyclidine on prepulse inhibition of the acoustic startle reflex and on prepulse-elicited reactivity in C57BL6 mice. Neuropsychopharmacology 29, 18651877.
  • Zetterström, R., Solomin, L., Jansson, L., Hoffer, B.J., Olson, L. & Perlmann, T. (1997) Dopamine neuron agenesis in Nurr1-deficient mice. Science 276, 248250.
  • Zetterström, R.H., Williams, R., Perlmann, T. & Olson, L. (1996) Cellular expression of the immediate early transcription factors Nurr1 and NGFI-B suggests a gene regulatory role in several brain regions including the nigrostriatal dopamine system. Brain Res Mol Brain Res 41, 111120.